MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1002/pros.24863

Медицинская библиотека · The Prostate · 2025

Assessing the Impact of Transition and Peripheral Zone PSA Densities Over Whole-Gland PSA Density for Prostate Cancer Detection on Multiparametric MRI.

Esengur Omer Tarik, Stevenson Emma, Stecko Hunter, Lay Nathan S, Yang Dong, Tetreault Jesse, Xu Ziyue, Xu Daguang, Yilmaz Enis C, Gelikman David G, Harmon Stephanie A, Merino Maria J, Gurram Sandeep, Wood Bradford J, Choyke Peter L, Pinto Peter A, Turkbey Baris

СтатьяНаблюдательное исследованиеПоддержка NIH: внешняя программаПеревод в очереди

Аннотация

BACKGROUND

Whole-gland (WG) prostate-specific antigen (PSA) density (PSAD) has proven useful in diagnosing to be beneficial in localized prostate cancer (PCa). This study aimed to evaluate the predictive performance of WG and zonal (transition zone [TZ] and peripheral zone [PZ]) PSAD in predicting PCa and clinically significant PCa (csPCa) in prostate MRI.

METHODS

A retrospective analysis was conducted on consecutive patients who underwent multiparametric MRI and MRI/US fusion-guided biopsy between March 2019 and July 2024. TZ-PSAD, PZ-PSAD, and WG-PSAD were calculated using in-house AI models. Optimal thresholds for TZ-PSAD and PZ-PSAD were determined using the Youden index from receiver operating characteristic (ROC) curve analyses with five-fold cross-validation, whereas 0.15 ng/mL2 was applied as the threshold for WG-PSAD. Statistical comparisons were performed using Wilcoxon rank-sum, χ2, and Fisher's exact tests. Logistic regression (LR) and area under the ROC curve (AUC) analyses with DeLong's test were conducted to evaluate diagnostic performance.

RESULTS

The study cohort included 774 consecutive patients (median age = 67 years [interquartile range {IQR}: 61-71], median WG-PSAD = 0.11 ng/mL2 [IQR: 0.07-0.17], median TZ-PSAD = 0.22 ng/mL2 [IQR: 0.12-0.41], median PZ-PSAD = 0.13 ng/mL2 [IQR: 0.16-0.34]). Among these patients, 475 had PCa and 341 had csPCa. The mean optimal thresholds for TZ-PSAD and PZ-PSAD were 0.20 ng/mL2 and 0.21 ng/mL2, respectively, for PCa, whereas they were 0.26 and 0.23, respectively, for csPCa. Multivariable LR identified TZ-PSAD (OR = 2.00, p = 0.03) and WG-PSAD (OR = 2.40, p = 0.02) as significant predictors of PCa. For csPCa, TZ-PSAD was the only independent predictor (OR = 2.13, p = 0.02) among PSAD measurements. TZ-PSAD showed a superior AUC for both PCa (0.79 ± 0.05) and csPCa (0.77 ± 0.02) compared to WG-PSAD (0.77 ± 0.06 for PCa, 0.76 ± 0.03 for csPCa) and PZ-PSAD (0.69 ± 0.06 for PCa, 0.70 ± 0.04 for csPCa; p < 0.001).

CONCLUSIONS

Both TZ-PSAD and WG-PSAD are strong predictors of PCa, but TZ-PSAD is a superior predictor of csPCa compared to WG-PSAD and PZ-PSAD. Further prospective studies are warranted to validate these findings.

TRIAL REGISTRATION: NCT03354416.

Для цитирования: Esengur Omer Tarik, Stevenson Emma, Stecko Hunter, Lay Nathan S, Yang Dong, Tetreault Jesse, Xu Ziyue, Xu Daguang, Yilmaz Enis C, Gelikman David G, Harmon Stephanie A, Merino Maria J, Gurram Sandeep, Wood Bradford J, Choyke Peter L, Pinto Peter A, Turkbey Baris. Assessing the Impact of Transition and Peripheral Zone PSA Densities Over Whole-Gland PSA Density for Prostate Cancer Detection on Multiparametric MRI.. The Prostate. 2025. DOI: 10.1002/pros.24863.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.